Abstract: A business method for pharmaceutical sales in which additional parties or entities are introduced into the transaction such that simultaneous mass manufacturing and seeking regulatory approvals for the sales of pharmaceutical is feasible. The method promotes the early widespread adoption and use of pharmaceuticals while reducing risk and increasing sales volume through guaranteed advance bulk purchase agreements. The resulting method achieves speed to mass markets heretofore not realized.

Abstract: A business method for pharmaceutical sales in which additional parties or entities are introduced into the transaction such that simultaneous mass manufacturing and seeking regulatory approvals for the sales of pharmaceutical is feasible. The method promotes the early widespread adoption and use of pharmaceuticals while reducing risk and increasing sales volume through guaranteed advance bulk purchase agreements. The resulting method achieves speed to mass markets heretofore not realized.

Abstract: A business method for pharmaceutical sales in which a single or multiple additional parties are introduced into the transaction such that a push market strategy results for the sales of pharmaceutical which are currently sold under patent licensing. The method promotes the widespread adoption of patented pharmaceuticals while reducing risk and increasing sales volume through guaranteed long term bulk purchase agreements. The resulting method lowers initial consumer prices of pharmaceuticals during the onset of early phase production while leveling prices toward the final phase of patent life.